Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BASILIXIMAB Cause Haemoglobin decreased? 142 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Haemoglobin decreased have been filed in association with BASILIXIMAB (Simulect). This represents 2.1% of all adverse event reports for BASILIXIMAB.

142
Reports of Haemoglobin decreased with BASILIXIMAB
2.1%
of all BASILIXIMAB reports
2
Deaths
57
Hospitalizations

How Dangerous Is Haemoglobin decreased From BASILIXIMAB?

Of the 142 reports, 2 (1.4%) resulted in death, 57 (40.1%) required hospitalization.

Is Haemoglobin decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BASILIXIMAB. However, 142 reports have been filed with the FAERS database.

What Other Side Effects Does BASILIXIMAB Cause?

Cytomegalovirus infection (590) Drug ineffective (567) Off label use (567) Transplant rejection (554) Kidney transplant rejection (456) Product use in unapproved indication (428) Pyrexia (323) Diarrhoea (314) Multiple organ dysfunction syndrome (298) Polyomavirus-associated nephropathy (298)

What Other Drugs Cause Haemoglobin decreased?

LENALIDOMIDE (4,031) RUXOLITINIB (3,297) ECULIZUMAB (3,028) ADALIMUMAB (2,459) CLOZAPINE (2,396) RITUXIMAB (1,803) APIXABAN (1,779) NIRAPARIB (1,759) METHOTREXATE (1,754) RIBAVIRIN (1,753)

Which BASILIXIMAB Alternatives Have Lower Haemoglobin decreased Risk?

BASILIXIMAB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH BASILIXIMAB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED BASILIXIMAB vs BCG VACCINE BASILIXIMAB vs BEBTELOVIMAB BASILIXIMAB vs BECLOMETHASONE

Related Pages

BASILIXIMAB Full Profile All Haemoglobin decreased Reports All Drugs Causing Haemoglobin decreased BASILIXIMAB Demographics